Italien - italiensk - Ministero della Salute

microimp srl - dispositivi per odontoiatria protesica - accessori

Den Europæiske Union - italiensk - EMA (European Medicines Agency)

amgen europe b.v. - blinatumomab - linfoma di leucemia linfoblastica a cellule precursori - agenti antineoplastici - blincyto is indicated as monotherapy for the treatment of adults with cd19 positive relapsed or refractory b precursor acute lymphoblastic leukaemia (all). patients with philadelphia chromosome positive b-precursor all should have failed treatment with at least 2 tyrosine kinase inhibitors (tkis) and have no alternative treatment options. blincyto is indicated as monotherapy for the treatment of adults with philadelphia chromosome negative cd19 positive b-precursor all in first or second complete remission with minimal residual disease (mrd) greater than or equal to 0. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with philadelphia chromosome negative cd19 positive b precursor all which is refractory or in relapse after receiving at least two prior therapies or in relapse after receiving prior allogeneic haematopoietic stem cell transplantation. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with high-risk first relapsed philadelphia chromosome negative cd19 positive b-precursor all as part of the consolidation therapy (see section 4.

Schweiz - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

padma ag - punicae granati polvere di semi, galangae rhizomatis in polvere, pepe lungo di frutta in polvere, cardamomi sperma in polvere, cannella cassiae corticis polvere - capsule - punicae granati polvere di semi di 204 mg, galangae rhizomatis polvere 102 mg, pepe lungo di frutta in polvere, il 25,5 mg, cardamomi sperma polvere 12.75 mg, cannella cassiae corticis polvere 12.75 mg, excipiens pro capsula. - nach den therapieprinzipien der tibetischen medizin bei verdauungsbeschwerden - tibetano medicinali

Italien - italiensk - AIFA (Agenzia Italiana del Farmaco)

fidia farmaceutici s.p.a. - aciclovir - aciclovir

Italien - italiensk - Ministero della Salute

zoetis italia s.r.l. - lincomicina cloridrato, spectinomicina solfato - lincomicina cloridrato - 56.7 milligrammo (i); spectinomicina solfato - nd, lincomicina cloridrato - 222 milligrammo (i); spectinomicina solfato - 444.7 milligrammo (i), spectinomicina solfato - 444.7 mg; lincomicina cloridrato - 222 mg, lincomicina cloridrato - 56.7 mg; spectinomicina solfato - nd, lincomicina cloridrato - 222 mg; spectinomicina solfato - 444.7 mg, spectinomicina solfato - nd ; lincomicina cloridrato - 56.7 mg - lincomycin, combinations

Italien - italiensk - Unimer

unimer - alto contenuto di carbonio organico umificato (carbonio umico e fulvico) - fertilizzanti ecologici

Italien - italiensk - Ministero della Salute

boehringer ingelheim animal health italia s.p.a - non contiene principi attivi - non contiene principi attivi - nd, sodio cloruro - 216.6 mg; potassio fosfato monobasico - 75.9 mg; sodio fosfato bibasico biidrato - 256.1 mg, potassio fosfato monobasico - 75.9 mg; sodio cloruro - 216.6 mg; sodio fosfato bibasico biidrato - 256.1 mg - solvents and diluting agents, incl. irrigating solutions

Italien - italiensk - Ministero della Salute

gardhen bilance s.r.l. - poltrone per terapia generica

Italien - italiensk - Ministero della Salute

sterilfarma srl -

Den Europæiske Union - italiensk - EMA (European Medicines Agency)

amgen europe b.v. - adalimumab - arthritis, psoriatic; spondylitis, ankylosing; crohn disease; colitis, ulcerative; hidradenitis suppurativa; psoriasis; arthritis, rheumatoid - immunosoppressori - si prega di fare riferimento alla sezione 4. 1 del riassunto delle caratteristiche del prodotto nel documento informativo del prodotto.